Sudhir Gupta
Overview
Explore the profile of Sudhir Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
3264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Gupta S, Agrawal A
Front Immunol
. 2023 Feb;
14:1080129.
PMID: 36756122
Dendritic cells (DCs) are crucial cells for initiating and maintaining immune response. They play critical role in homeostasis, inflammation, and autoimmunity. A number of molecules regulate their functions including synapse...
12.
Kobayashi R, Gupta S, Melamed I, Mandujano J, Kobayashi A, Ritchie B, et al.
Front Immunol
. 2023 Jan;
13:1110388.
PMID: 36605207
[This corrects the article DOI: 10.3389/fimmu.2019.00040.].
13.
Gupta S, Kobayashi R, Litzman J, Cherwin L, Hoeller S, Kreuwel H
Expert Rev Clin Immunol
. 2022 Nov;
19(1):7-17.
PMID: 36346032
Introduction: Human immunoglobulin (IG) administered intravenously (IVIG) or subcutaneously (SCIG) is used to prevent infections in patients with primary immunodeficiency diseases (PIDDs) such as primary antibody immunodeficiencies. Areas Covered: This...
14.
Roy S, Gupta S, Tourky R
J Econ Growth (Boston)
. 2022 Nov;
:1-42.
PMID: 36320344
Supplementary Information: The online version contains supplementary material available at 10.1007/s10887-022-09218-0.
15.
Kobayashi R, Litzman J, Melamed I, Mandujano J, Kobayashi A, Ritchie B, et al.
Clin Exp Immunol
. 2022 Oct;
210(2):91-103.
PMID: 36208448
A prospective study and its long-term extension examined whether weekly treatment of patients with primary immunodeficiencies (PIDs) with a 16.5% subcutaneous immunoglobulin (SCIg; cutaquig®) confers acceptable efficacy, safety, and tolerability...
16.
Kaur P, Kunwar A, Sharma M, Durgad K, Gupta S, Bhargava B
J Hum Hypertens
. 2022 Aug;
37(7):560-567.
PMID: 35945426
Hypertension is the leading single preventable risk factor for cardiovascular disease. The India Hypertension Control Initiative (IHCI) project was designed to improve hypertension control in public sector clinics. The project...
17.
Vollmer C, Dias A, Lopes L, Kasahara T, Delphim L, Silva J, et al.
Clin Transl Allergy
. 2022 Jun;
12(6):e12153.
PMID: 35734271
Background: Obesity has often been associated with severe allergic asthma (AA). Here, we analyzed the frequency of different circulating CD4T-cell subsets from lean, overweight and obese AA patients. Methods: Mononuclear...
18.
Gupta S, Yadav A, Antony A, Jana M, Goswami R, Yadav S, et al.
Indian J Pediatr
. 2022 Jun;
89(9):920.
PMID: 35727528
No abstract available.
19.
Gupta S, Demirdag Y, Gupta A
Front Immunol
. 2022 Jun;
13:864307.
PMID: 35669770
The role of CD4 T regulatory cells is well established in peripheral tolerance and the pathogenesis of the murine model and human autoimmune diseases. CD4 T regulatory cells (CD4 Tregs)...
20.
Gupta S, Agrawal S, Sandoval A, Su H, Tran M, Demirdag Y
J Clin Immunol
. 2022 Apr;
42(5):914-922.
PMID: 35366743
Purpose: CD8 cytotoxic T cells (CTLs) play a critical role in the clearance of virally infected cells. SARS-CoV-2-specific CD8 T cells and functional CTLs in natural infections and following COVID-19...